Gene burden data comprises gene–phenotype relationships observed in gene-level association tests using rare variant collapsing analyses from UK Biobank exome sequence data. The Platform integrates burden tests carried out by REGENERON (Wang, Q. et al, 2021), and the gene-level PheWAS maintained by the AstraZeneca PheWAS Portal and described in Backman, J.D. et al, 2021.